How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,128 results for

Child Safety Seat

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

81. CPG on Attention Deficit Hyperactivity Disorder (ADHD) in the Child and Adolescent Population

CPG on Attention Deficit Hyperactivity Disorder (ADHD) in the Child and Adolescent Population Clinical Practice Guideline on Attention De? cit Hyperactivity Disorder (ADHD) in Children and Adolescents CLINICAL PRACTICE GUIDELINES IN THE SPANISH NATIONAL HEALTHCARE SYSTEM MINISTRY OF HEALTH, SOCIAL POLICY , AND EQUALITY MINISTERIO DE SANIDAD, POLÍTICA SOCIAL E IGUALDADIt has been 5 years since the publication of this Clinical Practice Guideline and it is subject to updating. Clinical Practice (...) it include? Recommendations 7.2.3.1. Personalised and speci? c treatment of teaching in academic competences and skills is recommended for children and adolescents with ADHD and repercussion on academic performance. 7.2.4. In ADHD in children and adolescents:What adaptations are useful/recommendable in the school context? Recommendations B 7.2.4.1. When ADHD has a signi? cant impact on the child’s or adolescent’s academic competence, the schools should make adaptations to help them in the classroom

2010 GuiaSalud

82. A Brief MI Intervention in the ED to Increase Child Passenger Restraint Use

or disease Intervention/treatment Phase Child Restraint Systems Seat Belts Behavioral: Motivational Interviewing Behavioral: Tailored brochure Not Applicable Detailed Description: Motor vehicle collisions (MVCs) remain a leading cause of death among children after the first year of life despite substantial improvements in passenger safety. Deaths and severe injuries from MVCs can be reduced significantly through the consistent use of size-appropriate child passenger restraints. Still, 10% of children (...) . A Brief MI Intervention in the ED to Increase Child Passenger Restraint Use The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02496481 Recruitment Status : Completed First Posted : July 14, 2015 Last Update Posted : October 25, 2016 Sponsor: University of Michigan Collaborator: Hurley Medical Center

2015 Clinical Trials

83. Infant and Young Child Feces Management and Enabling Products for Their Hygienic Collection, Transport, and Disposal in Cambodia. (PubMed)

tools in the latrine were associated with hygienic disposal. The youngest caretakers with the newest latrines and youngest children were least likely to dispose of IYC feces hygienically, representing a key target group for interventions to improve hygienic disposal in Cambodia. Reusable diapers, child-friendly potties, and possibly latrine seats, that offer child safety, time and cost savings, and easy disposal and cleaning could potentially facilitate hygienic disposal for these ages. © (...) Infant and Young Child Feces Management and Enabling Products for Their Hygienic Collection, Transport, and Disposal in Cambodia. In Cambodia, children's feces are rarely disposed of in an improved sanitation facility. This study examines current practices and the role that enabling products may play in increasing hygienic management of infant and young child (IYC) feces in households with access to improved sanitation. A survey was conducted with the primary caregiver of a child under 5 years

Full Text available with Trip Pro

2015 American Journal of Tropical Medicine & Hygiene

84. Care2BWell: Worksite Wellness for Child Care

Care2BWell: Worksite Wellness for Child Care Care2BWell: Worksite Wellness for Child Care - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Care2BWell: Worksite Wellness for Child Care The safety (...) ): University of North Carolina, Chapel Hill Study Details Study Description Go to Brief Summary: This study will evaluate the efficacy of a 6-month child care-based intervention to improve workers' physical activity and other health-related behaviors compared to an attention control intervention (Healthy Lifestyles vs. Healthy Finances). The study sample will use a cluster randomized design and a sample of 104 child care centers and 416 child care workers (4 workers/center). The intervention arm

2015 Clinical Trials

85. Disparities in Age-Appropriate Child Passenger Restraint Use Among Children Aged 1 to 12 Years. (PubMed)

Disparities in Age-Appropriate Child Passenger Restraint Use Among Children Aged 1 to 12 Years. Observed racial disparities in child safety seat use have not accounted for socioeconomic factors. We hypothesized that racial differences in age-appropriate restraint use would be modified by socioeconomic status and child passenger safety information sources.A 2-site, cross-sectional tablet-based survey of parents seeking emergency care for their 1- to 12-year-old child was conducted between (...) October 2011 and May 2012. Parents provided self-report of child passenger safety practices, demographic characteristics, and information sources. Direct observation of restraint use was conducted in a subset of children at emergency department discharge. Age-appropriate restraint use was defined by Michigan law.Of the 744 eligible parents, 669 agreed to participate and 601 provided complete responses to key variables. White parents reported higher use of car seats for 1- to 3-year-olds and booster

Full Text available with Trip Pro

2014 Pediatrics

86. Parents' knowledge, attitude, and use of child restraints, Shantou, China. (PubMed)

primary schools, 24 kindergartens, and 4 hospitals. Drivers were asked about their knowledge of and attitude toward the use of child restraints. In September 2012, multivariate regression was used to evaluate the factors associated with increased child restraint use.Of 3333 children observed in vehicles, only 22 (0.6%) children were secured in child safety seats or booster seats and 292 (8.7%) children were wearing seatbelts. More than half (n=508, 56.1%) of the infants or toddlers were riding (...) Parents' knowledge, attitude, and use of child restraints, Shantou, China. China has not adopted national policies for child safety restraints in cars, although children are increasingly traveling in cars.To describe child restraint use, and parents' knowledge of and attitude toward child restraint in Shantou, China.An observational study and driver survey on child restraint use was conducted in the Southeast China city of Shantou in 2012. Observational sites included 22 middle schools, 31

2014 American journal of preventive medicine

87. Child Abuse and Neglect: Physical Abuse (Treatment)

assesses the caregivers' background, caregiving abilities and potential, environmental safety, risk for repeat abuse, and risk to other siblings. A variety of CPS service plan options are available, ranging from periodic contact with the child and family to removal of the child from the home, either temporarily or permanently, with termination of parental rights. The CPS process for child maltreatment cases typically involves the following steps: Intake - Screening of reports and acceptance of case (...) Initial risk assessment - Caregiver interviews, medical information gathering, home evaluation, and possibility of contact with law enforcement Case planning - Determination of safety for the child with essentially 3 options: (1) the child goes home with the caregiver with or without services depending on the circumstances, (2) the child is removed from home and family with caregivers' consent and offered services to assist them in working towards reunifying with the child, and (3) the child

2014 eMedicine Pediatrics

88. Medicaid-based child restraint system disbursement and education and the Vaccines For Children program: comparative cost-effectiveness

URL Other publications of related interest Durbin DR, Elliott MR, Winston FK. Belt-positioning booster seats and reduction in risk of injury among children in vehicle crashes. JAMA 2003;289:2835-40. Winston FK, Elliott MR, Chen IG, et al. Acute healthcare utilization by children after motor vehicles crashes. Accid Anal Prev 2004;36:507-11. Centers for Disease Control and Prevention. Motor-Vehicle Occupant Injury: Strategies for Increasing Use of Child Safety Seats, Increasing Use of Safety Belts (...) . The authors stated that the analysis was carried out from the perspectives of both society and the third-party payer (Medicaid). Effectiveness data: The clinical data came from a selection of known, relevant studies and databases such as the Partners for Child Passenger Safety database (an ongoing child-focused database created by The Children’s Hospital of Philadelphia and State Farm Mutual Automobile Insurance Company) and the Fatality Analysis Reporting System. The methods of data collection

2008 NHS Economic Evaluation Database.

89. Safety of OFS Combined With AI Endocrine Therapy in Chinese Premenopausal Breast Cancer Patients

or more studies before adding more. Safety of OFS Combined With AI Endocrine Therapy in Chinese Premenopausal Breast Cancer Patients (SEAT) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT02440230 Recruitment Status (...) Safety of OFS Combined With AI Endocrine Therapy in Chinese Premenopausal Breast Cancer Patients Safety of OFS Combined With AI Endocrine Therapy in Chinese Premenopausal Breast Cancer Patients - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one

2015 Clinical Trials

90. A Follow-on Study of the Long-Term Safety of Aripiprazole in Patients With Chronic Schizophrenia

was seated on a hard, firm chair. These items are rated on a five-point scale: 0 (none), 1 (minimal), 2 (mild), 3 (moderate), 4 (severe). The total score ranges from 0 to 40. Negative changes from baseline indicate an improvement, with higher negative values indicating better improvement. Number of Participants With Adverse Events (AEs) [ Time Frame: Baseline to Last Visit ] The AEs were one of the primary parameters to measure the safety and tolerability of individual participants. The AEs were captured (...) A Follow-on Study of the Long-Term Safety of Aripiprazole in Patients With Chronic Schizophrenia A Follow-on Study of the Long-Term Safety of Aripiprazole in Patients With Chronic Schizophrenia - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one

2015 Clinical Trials

91. Efficacy and Safety of Weekly Subcutaneous MLN1202 in Improving Diabetic Nephropathy in Participants With Macroalbuminuria

pressure >110, with blood pressure measured in the seated position after at least 5 minutes of rest) at Screening and Day 1. Has received dialysis within 3 months of Screening. Has infectious diseases or leg ulcers at Screening (all per discretion of Principal Investigator [PI]). Has severe concurrent disease which, in the judgment of the investigator, would interfere significantly with the assessments of safety and efficacy during this study. Has known infection with human immunodeficiency virus (HIV (...) Efficacy and Safety of Weekly Subcutaneous MLN1202 in Improving Diabetic Nephropathy in Participants With Macroalbuminuria Efficacy and Safety of Weekly Subcutaneous MLN1202 in Improving Diabetic Nephropathy in Participants With Macroalbuminuria - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached

2015 Clinical Trials

92. A Phase III Efficacy and Safety Study of Intravenous Retosiban Versus Placebo for Women in Spontaneous Preterm Labor

A Phase III Efficacy and Safety Study of Intravenous Retosiban Versus Placebo for Women in Spontaneous Preterm Labor A Phase III Efficacy and Safety Study of Intravenous Retosiban Versus Placebo for Women in Spontaneous Preterm Labor - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number (...) of saved studies (100). Please remove one or more studies before adding more. A Phase III Efficacy and Safety Study of Intravenous Retosiban Versus Placebo for Women in Spontaneous Preterm Labor (NEWBORN-1) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02377466 Recruitment Status : Terminated (Asset

2015 Clinical Trials

93. Car Safety Seat and Gastroesophageal Reflux Disease

Car Safety Seat and Gastroesophageal Reflux Disease Car Safety Seat and Gastroesophageal Reflux Disease - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Car Safety Seat and Gastroesophageal Reflux Disease (...) episodes, which was significantly higher in the car safety seat. Larger trials are needed for decisive conclusions. Condition or disease Intervention/treatment Phase Gastroesophageal Reflux Disease and Position Device: car safety seat Not Applicable Detailed Description: OBJECTIVE - Over the past few decades, an increase in gastroesophageal reflux disease (GERD) has been seen in infants. This increase may be due to a continuous growth in the use of car safety seats. The objective of this study

2010 Clinical Trials

94. Safety Skills Training For Parents of Preschool Children

materials converted to web-based materials. Outcome Measures Go to Primary Outcome Measures : Behavioral measure: Change from baseline in identification of correct/incorrect child car safety seat and booster seat situations and bicycle helmet placement situations. [ Time Frame: 30 days and 60 days ] Parents viewed child car seat and booster seat situations and were asked whether 9 car safety seat and 7 booster seat items were correct or incorrect. Parents also viewed 2 bicycle helmet situations and were (...) and .89 for older children.) All items were assessed using a 5-point Likert scale with 1 = strongly disagree to 5 = strongly agree. Change in car safety knowledge of injury prevention [ Time Frame: 30 days and 60 days ] Three items were used to assess knowledge of car safety injury prevention (e.g., "Your child should use a forward-facing safety seat until…") with the response coded as either 0 = incorrect or 1 = correct. Change in car safety attitudes & beliefs of injury prevention [ Time Frame: 30

2014 Clinical Trials

95. Safety Skills Training: Parents of School-Aged Children

: Behavioral measure: identification of correct/incorrect car booster safety seat, seat belt, and bicycle helmet placement [ Time Frame: Immediate posttest and 30-day follow-up ] Parents viewed 2 car seat installations and were asked whether 7 car booster safety seat situations (e.g., age of the child for the seat) and 7 seat belt installations (e.g., placement of the seat belt) were correct or incorrect. Parents also viewed a bicycle helmet on a dummy and were asked to identify whether 2 helmet situations (...) Children (SAS_2) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02329340 Recruitment Status : Completed First Posted : December 31, 2014 Last Update Posted : December 31, 2014 Sponsor: Oregon Center for Applied Science, Inc. Collaborator: Eunice Kennedy Shriver National Institute of Child Health

2014 Clinical Trials

96. Efficacy and Safety of Fluticasone Propionate(FP)/ Salmeterol Xinafoate (SLM) Hydro Fluoro Alkane (HFA) Metered Dose Inhaler (MDI) in Pediatric Patients With Bronchial Asthma

Efficacy and Safety of Fluticasone Propionate(FP)/ Salmeterol Xinafoate (SLM) Hydro Fluoro Alkane (HFA) Metered Dose Inhaler (MDI) in Pediatric Patients With Bronchial Asthma Efficacy and Safety of Fluticasone Propionate(FP)/ Salmeterol Xinafoate (SLM) Hydro Fluoro Alkane (HFA) Metered Dose Inhaler (MDI) in Pediatric Patients With Bronchial Asthma - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information (...) . Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Efficacy and Safety of Fluticasone Propionate(FP)/ Salmeterol Xinafoate (SLM) Hydro Fluoro Alkane (HFA) Metered Dose Inhaler (MDI) in Pediatric Patients With Bronchial Asthma The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does

2014 Clinical Trials

97. An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension

An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more (...) studies before adding more. An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02235909 Recruitment Status : Active, not recruiting First Posted : September 10, 2014 Last Update Posted : March 12, 2019 Sponsor: Arbor

2014 Clinical Trials

98. Safety, Tolerability, and Pharmacokinetic Study of Single Ascending Doses of GC021109 in Healthy Subjects

. Female subjects of child-bearing potential. Female subjects who are pregnant or lactating. Positive urine drug or urine alcohol results at screening or check-in. Positive urine cotinine at screening. Positive results at screening for HIV, hepatitis B surface antigen (HBsAg), or hepatitis C virus (HCV). Seated blood pressure is less than 90/40 mmHg or greater than 140/90 mmHg at screening. Seated heart rate is lower than 40 bpm or higher than 99 bpm at screening. Orthostatic vital sign results (...) Safety, Tolerability, and Pharmacokinetic Study of Single Ascending Doses of GC021109 in Healthy Subjects Safety, Tolerability, and Pharmacokinetic Study of Single Ascending Doses of GC021109 in Healthy Subjects - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100

2014 Clinical Trials

99. Evaluation of the Safety, Efficacy and Pharmacokinetics of MICARDIS® (Telmisartan) in Children and Adolescents With Hypertension

Evaluation of the Safety, Efficacy and Pharmacokinetics of MICARDIS® (Telmisartan) in Children and Adolescents With Hypertension Evaluation of the Safety, Efficacy and Pharmacokinetics of MICARDIS® (Telmisartan) in Children and Adolescents With Hypertension - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have (...) reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Evaluation of the Safety, Efficacy and Pharmacokinetics of MICARDIS® (Telmisartan) in Children and Adolescents With Hypertension The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02242344 Recruitment

2014 Clinical Trials

100. Efficacy and Safety Evaluating Study to Compare Kanarb (Fimasartan) and Cozaar® (Losartan) in Adult Patients With Grade I-II Arterial Hypertension

& DOHME B.V., Netherlands, . For subjects administered with anti-hypertensive drugs: the anti-hypertensive drug may be safely cancelled during the "wash-out" period according to the investigator's judgment. For women of child-bearing potential: negative urine pregnancy test at screening (Day -14). 8. Systolic blood pressure (SBP) (when seated) at Randomization (Day 0) ≥140 mmHg and ≤179 mmHg. 9. For women of child-bearing potential: negative urine pregnancy test at Randomization (Day 0) Exclusion (...) Efficacy and Safety Evaluating Study to Compare Kanarb (Fimasartan) and Cozaar® (Losartan) in Adult Patients With Grade I-II Arterial Hypertension Efficacy and Safety Evaluating Study to Compare Kanarb (Fimasartan) and Cozaar® (Losartan) in Adult Patients With Grade I-II Arterial Hypertension - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies

2014 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>